Clinical Trial Update: Rivaroxaban Plus ASA in Embolic Stroke of Undetermined Source(AREST-ESUS) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates for rivaroxaban plus aspirin in embolic stroke of undetermined source (AREST-ESUS) across Phase 2 and Phase 3, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Stroke, Prevention | Phase 2, Phase 3 | Status: COMPLETED